Abstract |
Aging populations with neurodegenerative disorders will gradually become a greater problem for society. Serum deprivation-induced cell death is recognized as one of the standard models for the study of neurotoxicity. Increasing evidence indicates that cGMP/PKG pathway may play a rescue role in serum deprivation-induced toxicity. The aim of this study was to investigate protective effects of KMUP-1, an enhancer of cGMP/PKG signaling on serum deprivation-induced neurotoxicity in SH-SY5Y neuroblastoma cells. Under normal serum condition, KMUP-1 enhanced protein expression of nNOS, PKG and sGCalpha1, increased intracellular cyclic GMP level, and attenuated PDE5 expression. KMUP-1 also increased expression of BDNF and Bcl-2, but it did not affect Bax expression. The phosphorylation of Akt and CREB induced by KMUP-1 was inhibited by tyrosine kinase (TrK) inhibitor K252a and phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002, respectively. Under serum deprivation condition, flow cytometric analysis using Annexin V showed KMUP-1 increased cell viability, but lacked protective effects in the presence of nitric oxide synthase inhibitor l-NAME, PKG inhibitor Rp-8-pCPT-cGMPS or LY294002. KMUP-1 not only enhanced expression of nNOS, sGCalpha1, PKG, p-CREB, p-Akt and Bcl-2, but also attenuated Bax expression in serum deprivation-treated cultures. In conclusion, cGMP/PKG, PI3K/Akt/CREB and Bcl-2/Bax signals play critical roles in the neuroprotective effects of KMUP-1 on serum deprivation-induced toxicity.
|
Authors | Ya-Yun Hsu, Chi-Ming Liu, Hsin-Hung Tsai, Yuh-Jyh Jong, Ing-Jun Chen, Yi-Ching Lo |
Journal | Toxicology
(Toxicology)
Vol. 268
Issue 1-2
Pg. 46-54
(Jan 31 2010)
ISSN: 1879-3185 [Electronic] Ireland |
PMID | 19962417
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | 2009 Elsevier Ireland Ltd. All rights reserved. |
Chemical References |
- Brain-Derived Neurotrophic Factor
- Culture Media, Serum-Free
- Piperidines
- Xanthines
- bcl-2-Associated X Protein
- KMUP 1
- Nitric Oxide
- Cyclic AMP
- Nitric Oxide Synthase Type I
- Phosphatidylinositol 3-Kinases
- Proto-Oncogene Proteins c-akt
- Cyclic GMP-Dependent Protein Kinases
- Cyclic Nucleotide Phosphodiesterases, Type 5
|
Topics |
- Blotting, Western
- Brain-Derived Neurotrophic Factor
(metabolism)
- Cell Line, Tumor
- Culture Media, Serum-Free
- Cyclic AMP
(pharmacology)
- Cyclic GMP-Dependent Protein Kinases
(metabolism)
- Cyclic Nucleotide Phosphodiesterases, Type 5
(metabolism)
- Humans
- Nervous System
(drug effects, enzymology, metabolism)
- Nitric Oxide
(metabolism)
- Nitric Oxide Synthase Type I
(metabolism)
- Phosphatidylinositol 3-Kinases
(metabolism)
- Piperidines
(pharmacology)
- Proto-Oncogene Proteins c-akt
(metabolism)
- Up-Regulation
(drug effects)
- Xanthines
(pharmacology)
- bcl-2-Associated X Protein
(metabolism)
|